These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37060790)

  • 21. Lesser protein degradation machinery correlates with higher BM86 tick vaccine efficacy in Rhipicephalus annulatus when compared to Rhipicephalus microplus.
    Popara M; Villar M; Mateos-Hernández L; de Mera IG; Marina A; del Valle M; Almazán C; Domingos A; de la Fuente J
    Vaccine; 2013 Oct; 31(42):4728-35. PubMed ID: 23973246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of tick infestations in cattle vaccinated with bacterial membranes containing surface-exposed tick protective antigens.
    Almazán C; Moreno-Cantú O; Moreno-Cid JA; Galindo RC; Canales M; Villar M; de la Fuente J
    Vaccine; 2012 Jan; 30(2):265-72. PubMed ID: 22085549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a glycine-rich protein from Rhipicephalus microplus: tissue expression, gene silencing and immune recognition.
    Leal BF; Alzugaray MF; Seixas A; Da Silva Vaz I; Ferreira CAS
    Parasitology; 2018 Jun; 145(7):927-938. PubMed ID: 29144218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective efficacy of bacterial membranes containing surface-exposed BM95 antigenic peptides for the control of cattle tick infestations.
    Canales M; Labruna MB; Soares JF; Prudencio CR; de la Fuente J
    Vaccine; 2009 Dec; 27(52):7244-8. PubMed ID: 19835826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of immunogenic proteins from ovarian tissue and recognized in larval extracts of Rhipicephalus (Boophilus) microplus, through an immunoproteomic approach.
    Ramírez Rodríguez PB; Rosario Cruz R; Domínguez García DI; Hernández Gutiérrez R; Lagunes Quintanilla RE; Ortuño Sahagún D; González Castillo C; Gutiérrez Ortega A; Herrera Rodríguez SE; Vallejo Cardona A; Martínez Velázquez M
    Exp Parasitol; 2016 Nov; 170():227-235. PubMed ID: 27729251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine immunisation with a recombinant peptide derived from synthetic SBm7462® (Bm86 epitope construct) immunogen for Rhipicephalus microplus control.
    Patarroyo S JH; de Sousa Neves E; Fidelis CF; Tafur-Gómez GA; de Araujo L; Vargas MI; Sossai S; Prates-Patarroyo PA
    Ticks Tick Borne Dis; 2020 Sep; 11(5):101461. PubMed ID: 32723656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhipicephalus (Boophilus) microplus: clotting time in tick-infested skin varies according to local inflammation and gene expression patterns in tick salivary glands.
    Carvalho WA; Maruyama SR; Franzin AM; Abatepaulo AR; Anderson JM; Ferreira BR; Ribeiro JM; Moré DD; Augusto Mendes Maia A; Valenzuela JG; Garcia GR; de Miranda Santos IK
    Exp Parasitol; 2010 Apr; 124(4):428-35. PubMed ID: 20045690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel β-adrenergic octopamine receptor-like gene (βAOR-like) and increased ATP-binding cassette B10 (ABCB10) expression in a Rhipicephalus microplus cell line derived from acaricide-resistant ticks.
    Koh-Tan HH; Strachan E; Cooper K; Bell-Sakyi L; Jonsson NN
    Parasit Vectors; 2016 Aug; 9(1):425. PubMed ID: 27484910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhipicephalus (Boophilus) microplus tick in vitro feeding methods for functional (dsRNA) and vaccine candidate (antibody) screening.
    Lew-Tabor AE; Bruyeres AG; Zhang B; Rodriguez Valle M
    Ticks Tick Borne Dis; 2014 Sep; 5(5):500-10. PubMed ID: 24875450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential recognition by tick-resistant cattle of the recombinantly expressed Rhipicephalus microplus serine protease inhibitor-3 (RMS-3).
    Rodriguez-Valle M; Vance M; Moolhuijzen PM; Tao X; Lew-Tabor AE
    Ticks Tick Borne Dis; 2012 Jun; 3(3):159-69. PubMed ID: 22608113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine immunoprotection against Rhipicephalus (Boophilus) microplus with recombinant Bm86-Campo Grande antigen.
    Cunha RC; Pérez de León AA; Leite FP; Pinto Lda S; Dos Santos Júnior AG; Andreotti R
    Rev Bras Parasitol Vet; 2012; 21(3):254-62. PubMed ID: 23070436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mining a differential sialotranscriptome of Rhipicephalus microplus guides antigen discovery to formulate a vaccine that reduces tick infestations.
    Maruyama SR; Garcia GR; Teixeira FR; Brandão LG; Anderson JM; Ribeiro JMC; Valenzuela JG; Horackova J; Veríssimo CJ; Katiki LM; Banin TM; Zangirolamo AF; Gardinassi LG; Ferreira BR; de Miranda-Santos IKF
    Parasit Vectors; 2017 Apr; 10(1):206. PubMed ID: 28446245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression analysis for subolesin in Rhipicephalus microplus infected with Anaplasma marginale.
    Carvajal-de la Fuente V; Merino-Charrez O; Tovar-Carman E; Rodríguez-Camarillo SD; Lagunes-Quintanilla RE; Muñoz-Tenería FA; Contreras M; de la Fuente J
    Exp Appl Acarol; 2018 Oct; 76(2):229-241. PubMed ID: 30302627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoprotection evaluation of the recombinant N-terminal domain of Cys-loop receptors against Rhipicephalus (Boophilus) microplus tick infestation.
    Martínez Velázquez M; Barragán Álvarez CP; Flores Fernández JM; Lagunes Quintanilla RE; Saines EC; Ramírez Rodríguez PB; Herrera Rodríguez SE; Gutiérrez RH; Ortega AG; Álvarez ÁH
    Parasite; 2021; 28():65. PubMed ID: 34533454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhipicephalus microplus: An overview of vaccine antigens against the cattle tick.
    Pereira DFS; Ribeiro HS; Gonçalves AAM; da Silva AV; Lair DF; de Oliveira DS; Boas DFV; Conrado IDSS; Leite JC; Barata LM; Reis PCC; Mariano RMDS; Santos TAP; Coutinho DCO; Gontijo NF; Araujo RN; Galdino AS; Paes PRO; Melo MM; Nagem RAP; Dutra WO; Silveira-Lemos DD; Rodrigues DS; Giunchetti RC
    Ticks Tick Borne Dis; 2022 Jan; 13(1):101828. PubMed ID: 34628330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant peptides as new immunogens for the control of the bovine tick, Rhipicephalus (Boophilus) microplus.
    Prudencio CR; Marra AO; Cardoso R; Goulart LR
    Vet Parasitol; 2010 Aug; 172(1-2):122-31. PubMed ID: 20488622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of cattle with synthetic peptides corresponding to predicted extracellular domains of Rhipicephalus (Boophilus) microplus aquaporin 2 reduced the number of ticks feeding to repletion.
    Scoles GA; Hussein HE; Olds CL; Mason KL; Davis SK
    Parasit Vectors; 2022 Feb; 15(1):49. PubMed ID: 35135602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of ferritin 2 for the control of tick infestations.
    Hajdusek O; Almazán C; Loosova G; Villar M; Canales M; Grubhoffer L; Kopacek P; de la Fuente J
    Vaccine; 2010 Apr; 28(17):2993-8. PubMed ID: 20171306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of cattle tick Rhipicephalus (Boophilus) microplus saliva: a comparison between partially and fully engorged females.
    Tirloni L; Reck J; Terra RM; Martins JR; Mulenga A; Sherman NE; Fox JW; Yates JR; Termignoni C; Pinto AF; Vaz Ida S
    PLoS One; 2014; 9(4):e94831. PubMed ID: 24762651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subolesin: a candidate vaccine antigen for the control of cattle tick infestations in Indian situation.
    Shakya M; Kumar B; Nagar G; de la Fuente J; Ghosh S
    Vaccine; 2014 Jun; 32(28):3488-94. PubMed ID: 24795229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.